Boston Scientific (BSX) EBT Margin (2009 - 2026)
Boston Scientific recorded quarterly EBT Margin of 22.33% in Q1 2026, up 68.65% quarter-over-quarter from 13.24% in Q4 2025, and up 507.0% year-over-year from 3.68% in Q1 2025.
Boston Scientific's EBT Margin history runs 18 years deep, the most recent figure standing at 22.33% for Q1 2026.
- In Q1 2026, EBT Margin rose 507.0% year-over-year to 22.33%; the TTM figure through Mar 2026 stood at 18.15% (up 403.0% YoY), while the FY2025 annual figure was 16.86%, up 324.0% from the prior year.
- EBT Margin came in at 22.33% for Q1 2026 at Boston Scientific, up from 13.24% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 22.33% in Q1 2026 to a low of 5.16% in Q1 2022.
- A 5-year average of 13.89% and a median of 13.24% in 2025 frame the typical range for EBT Margin.
- Across the five-year window, EBT Margin plunged 874 bps in 2022 and soared 957 bps in 2023, its largest moves.
- Boston Scientific's EBT Margin stood at 12.21% in 2022, then rose by 11 bps to 13.56% in 2023, then retreated by 5 bps to 12.83% in 2024, then climbed by 3 bps to 13.24% in 2025, then surged by 69 bps to 22.33% in 2026.
- According to Business Quant data, EBT Margin over the past three periods registered 22.33%, 13.24%, and 18.54% for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 15.57% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 27.84% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4.87% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 22.61% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.84% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.17% |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 14.44% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.33% |
| Dec 31, 2025 | 13.24% |
| Sep 30, 2025 | 18.54% |
| Jun 30, 2025 | 18.59% |
| Mar 31, 2025 | 17.26% |
| Dec 31, 2024 | 12.83% |
| Sep 30, 2024 | 15.89% |
| Jun 30, 2024 | 10.19% |
| Mar 31, 2024 | 15.77% |
| Dec 31, 2023 | 13.56% |
| Sep 30, 2023 | 17.30% |
| Jun 30, 2023 | 11.84% |
| Mar 31, 2023 | 13.10% |
| Dec 31, 2022 | 12.21% |
| Sep 30, 2022 | 7.73% |
| Jun 30, 2022 | 10.64% |
| Mar 31, 2022 | 5.16% |
| Dec 31, 2021 | 3.81% |
| Sep 30, 2021 | 16.47% |
| Jun 30, 2021 | 4.84% |
| Mar 31, 2021 | 11.81% |
| Dec 31, 2020 | 11.33% |
| Sep 30, 2020 | -8.54% |
| Jun 30, 2020 | -9.04% |
| Mar 31, 2020 | 0.87% |
| Dec 31, 2019 | -0.21% |
| Sep 30, 2019 | 3.36% |
| Jun 30, 2019 | 5.51% |
| Mar 31, 2019 | 18.33% |
| Dec 31, 2018 | 11.56% |
| Sep 30, 2018 | 19.06% |
| Jun 30, 2018 | 13.94% |
| Mar 31, 2018 | 13.58% |
| Dec 31, 2017 | 9.43% |
| Sep 30, 2017 | 13.91% |
| Jun 30, 2017 | 4.03% |
| Mar 31, 2017 | 14.12% |
| Dec 31, 2016 | 4.06% |
| Sep 30, 2016 | 12.21% |
| Jun 30, 2016 | -18.67% |
| Mar 31, 2016 | 11.61% |
| Dec 31, 2015 | -17.09% |
| Sep 30, 2015 | -19.44% |
| Jun 30, 2015 | 5.70% |
| Mar 31, 2015 | -2.88% |
| Dec 31, 2014 | -29.36% |
| Sep 30, 2014 | 0.16% |
| Jun 30, 2014 | -5.55% |
| Mar 31, 2014 | 8.23% |
| Dec 31, 2013 | 3.21% |
| Sep 30, 2013 | -2.31% |
| Jun 30, 2013 | 8.40% |
| Mar 31, 2013 | -22.37% |
| Dec 31, 2012 | 2.86% |
| Sep 30, 2012 | -38.21% |
| Jun 30, 2012 | -197.92% |
| Mar 31, 2012 | 6.59% |
| Dec 31, 2011 | 5.41% |
| Sep 30, 2011 | 5.92% |
| Jun 30, 2011 | 8.00% |
| Mar 31, 2011 | 14.18% |
| Dec 31, 2010 | 11.44% |
| Sep 30, 2010 | 8.51% |
| Jun 30, 2010 | 6.17% |
| Mar 31, 2010 | -80.36% |
| Dec 31, 2009 | -64.79% |
| Sep 30, 2009 | -2.17% |
| Jun 30, 2009 | 8.68% |
| Mar 31, 2009 | -4.83% |